Please enable Javascript

Labmeeting uses lots of Javascript - basically you can't use the site without it. So please enable Javascript in your browser. If your browser does not support Javascript, we recommend Firefox.

Papers authored by Enjyoji K

Collect these papers and discover other ones on Labmeeting. Learn more.

Isolated CD39 Expression on CD4 T Cells Denotes both Regulatory and Memory Populations.

+ cite this

+ View Abstract

Zhou Q, Yan J, Putheti P, Wu Y, Sun X, Toxavidis V, Tigges J, Kassam N, Enjyoji K, Robson SC, Strom TB, and Gao W

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 9(10):2303-11, 2009 Oct - Who cited this? | PubMed ID: 19656134 | Fulltext

From the Cover: CD39 deletion exacerbates experimental murine colitis and human polymorphisms increase susceptibility to inflammatory bowel disease.

+ cite this

+ View Abstract

Friedman DJ, Künzli BM, A-Rahim YI, Sevigny J, Berberat PO, Enjyoji K, Csizmadia E, Friess H, and Robson SC

Proceedings of the National Academy of Sciences of the United States of America 106(39):16788-93, 2009 Sep 29 - Who cited this? | PubMed ID: 19805374 | Fulltext

Vascular smooth muscle cell expression of ectonucleotidase CD39 (ENTPD1) is required for neointimal formation in mice.

+ cite this

+ View Abstract

Behdad A, Sun X, Khalpey Z, Enjyoji K, Wink M, Wu Y, Usheva A, and Robson SC

Purinergic signalling 5(3):335-42, 2009 Sep - Who cited this? | PubMed ID: 19308674 | Fulltext

Vascular stasis, intestinal hemorrhage, and heightened vascular permeability complicate acute portal hypertension in cd39-null mice.

+ cite this

+ View Abstract

Sun X, Cárdenas A, Wu Y, Enjyoji K, and Robson SC

American journal of physiology. Gastrointestinal and liver physiology 297(2):G306-11, 2009 Aug - Who cited this? | PubMed ID: 19520738 | Fulltext

Preservation of cochlear function in Cd39 deficient mice.

+ cite this

+ View Abstract

Vlajkovic SM, Housley GD, Thorne PR, Gupta R, Enjyoji K, Cowan PJ, Charles Liberman M, and Robson SC

Hearing research 253(1-2):77-82, 2009 Jul - Who cited this? | PubMed ID: 19327391 | Fulltext

Functional ENTPD1 Polymorphisms in African Americans With Diabetes and End-Stage Renal Disease.

+ cite this

+ View Abstract

Friedman DJ, Talbert ME, Bowden DW, Freedman BI, Mukanya Y, Enjyoji K, and Robson SC

Diabetes 58(4):999-1006, 2009 Apr - Who cited this? | PubMed ID: 19095759 | Fulltext

Regulated Catalysis of Extracellular Nucleotides by Vascular CD39/ENTPD1 Is Required for Liver Regeneration.

+ cite this

+ View Abstract

Beldi G, Wu Y, Sun X, Imai M, Enjyoji K, Csizmadia E, Candinas D, Erb L, and Robson SC

Gastroenterology 135(5):1751-60, 2008 Nov - Who cited this? | PubMed ID: 18804472 | Fulltext

Natural killer T cell dysfunction in CD39-null mice protects against concanavalin A-induced hepatitis.

+ cite this

+ View Abstract

Beldi G, Wu Y, Banz Y, Nowak M, Miller L, Enjyoji K, Haschemi A, Yegutkin GG, Candinas D, Exley M, and Robson SC

Hepatology (Baltimore, Md.) 48(3):841-52, 2008 Sep - Who cited this? | PubMed ID: 18752325 | Fulltext

HVJ-AVE liposome-mediated Tissue Factor Pathway Inhibitor (TFPI) gene transfer with recombinant TFPI (rTFPI) irrigation attenuates restenosis in atherosclerotic arteries.

+ cite this

+ View Abstract

Yin X, Fu Y, Yutani C, Ikeda Y, Enjyoji K, and Kato H

International journal of cardiology, 2008 Jun 28 - Who cited this? | PubMed ID: 18590936 | Fulltext

Deletion of Cd39/Entpd1 results in hepatic insulin resistance.

+ cite this

+ View Abstract

Enjyoji K, Ko K, Thukral C, Blumel B, Sun X, Wu Y, Imai M, Friedman D, Csizmadia E, Bleibel W, Kahn BB, and Robson SC

Diabetes, 2008 Jun 20 - Who cited this? | PubMed ID: 18567823 | Fulltext

Tubuloglomerular feedback and renin secretion in NTPDase1/CD39-deficient mice.

+ cite this

+ View Abstract

Oppermann M, Friedman DJ, Faulhaber-Walter R, Mizel D, Castrop H, Enjyoji K, Robson SC, and Schnermann J

American journal of physiology. Renal physiology 294(4):F965-70, 2008 Apr - Who cited this? | PubMed ID: 18256308 | Fulltext

The ectonucleotidase cd39/ENTPDase1 modulates purinergic-mediated microglial migration.

+ cite this

+ View Abstract

Färber K, Markworth S, Pannasch U, Nolte C, Prinz V, Kronenberg G, Gertz K, Endres M, Bechmann I, Enjyoji K, Robson SC, and Kettenmann H

Glia 56(3):331-41, 2008 Feb - Who cited this? | PubMed ID: 18098126 | Fulltext

The role of purinergic signaling in the liver and in transplantation: effects of extracellular nucleotides on hepatic graft vascular injury, rejection and metabolism.

+ cite this

+ View Abstract

Beldi G, Enjyoji K, Wu Y, Miller L, Banz Y, Sun X, and Robson SC

Frontiers in bioscience : a journal and virtual library 13:2588-603, 2008 - Who cited this? | PubMed ID: 17981736 | Fulltext

Disordered pancreatic inflammatory responses and inhibition of fibrosis in CD39-null mice.

+ cite this

+ View Abstract

Künzli BM, Nuhn P, Enjyoji K, Banz Y, Smith RN, Csizmadia E, Schuppan D, Berberat PO, Friess H, and Robson SC

Gastroenterology 134(1):292-305, 2008 Jan - Who cited this? | PubMed ID: 18036594 | Fulltext

Disordered purinergic signaling inhibits pathological angiogenesis in cd39/Entpd1-null mice.

+ cite this

+ View Abstract

Jackson SW, Hoshi T, Wu Y, Sun X, Enjyoji K, Cszimadia E, Sundberg C, and Robson SC

The American journal of pathology 171(4):1395-404, 2007 Oct - Who cited this? | PubMed ID: 17823293 | Fulltext

The vascular ectonucleotidase ENTPD1 is a novel renoprotective factor in diabetic nephropathy.

+ cite this

+ View Abstract

Friedman DJ, Rennke HG, Csizmadia E, Enjyoji K, and Robson SC

Diabetes 56(9):2371-9, 2007 Sep - Who cited this? | PubMed ID: 17473221 | Fulltext

Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression.

+ cite this

+ View Abstract

Deaglio S, Dwyer KM, Gao W, Friedman D, Usheva A, Erat A, Chen JF, Enjyoji K, Linden J, Oukka M, Kuchroo VK, Strom TB, and Robson SC

The Journal of experimental medicine 204(6):1257-65, 2007 Jun 11 - Who cited this? | PubMed ID: 17502665 | Fulltext

Ecto-nucleotidases of the CD39/NTPDase family modulate platelet activation and thrombus formation: Potential as therapeutic targets.

+ cite this

+ View Abstract

Atkinson B, Dwyer K, Enjyoji K, and Robson SC

Blood cells, molecules & diseases 36(2):217-22, 2006 - Who cited this? | PubMed ID: 16476557 | Fulltext

Ectonucleotidases of CD39 family modulate vascular inflammation and thrombosis in transplantation.

+ cite this

+ View Abstract

Robson SC, Wu Y, Sun X, Knosalla C, Dwyer K, and Enjyoji K

Seminars in thrombosis and hemostasis 31(2):217-33, 2005 Apr - Who cited this? | PubMed ID: 15852225 | Fulltext

Beneficial effects of CD39/ecto-nucleoside triphosphate diphosphohydrolase-1 in murine intestinal ischemia-reperfusion injury.

+ cite this

+ View Abstract

Guckelberger O, Sun XF, Sévigny J, Imai M, Kaczmarek E, Enjyoji K, Kruskal JB, and Robson SC

Thrombosis and haemostasis 91(3):576-86, 2004 Mar - Who cited this? | PubMed ID: 14983235 | Fulltext

Coordinated adenine nucleotide phosphohydrolysis and nucleoside signaling in posthypoxic endothelium: role of ectonucleotidases and adenosine A2B receptors.

+ cite this

+ View Abstract

Eltzschig HK, Ibla JC, Furuta GT, Leonard MO, Jacobson KA, Enjyoji K, Robson SC, and Colgan SP

The Journal of experimental medicine 198(5):783-96, 2003 Sep 1 - Who cited this? | PubMed ID: 12939345 | Fulltext

Normal levels of anticoagulant heparan sulfate are not essential for normal hemostasis.

+ cite this

+ View Abstract

HajMohammadi S, Enjyoji K, Princivalle M, Christi P, Lech M, Beeler D, Rayburn H, Schwartz JJ, Barzegar S, de Agostini AI, Post MJ, Rosenberg RD, and Shworak NW

The Journal of clinical investigation 111(7):989-99, 2003 Apr - Who cited this? | PubMed ID: 12671048 | Fulltext

Tissue factor pathway inhibitor gene delivery using HVJ-AVE liposomes markedly reduces restenosis in atherosclerotic arteries.

+ cite this

+ View Abstract

Yin X, Yutani C, Ikeda Y, Enjyoji K, Ishibashi-Ueda H, Yasuda S, Tsukamoto Y, Nonogi H, Kaneda Y, and Kato H

Cardiovascular research 56(3):454-63, 2002 Dec - Who cited this? | PubMed ID: 12445886 | Fulltext

CD39 is the dominant Langerhans cell-associated ecto-NTPDase: modulatory roles in inflammation and immune responsiveness.

+ cite this

+ View Abstract

Mizumoto N, Kumamoto T, Robson SC, Sévigny J, Matsue H, Enjyoji K, and Takashima A

Nature medicine 8(4):358-65, 2002 Apr - Who cited this? | PubMed ID: 11927941 | Fulltext

Aggregation of beta(2)-glycoprotein I induced by sodium lauryl sulfate and lysophospholipids.

+ cite this

+ View Abstract

Hagihara Y, Hong DP, Hoshino M, Enjyoji K, Kato H, and Goto Y

Biochemistry 41(3):1020-6, 2002 Jan 22 - Who cited this? | PubMed ID: 11790126 | Fulltext

Disordered cellular migration and angiogenesis in cd39-null mice.

+ cite this

+ View Abstract

Goepfert C, Sundberg C, Sévigny J, Enjyoji K, Hoshi T, Csizmadia E, and Robson S

Circulation 104(25):3109-15, 2001 Dec 18 - Who cited this? | PubMed ID: 11748109 | Fulltext

Production of tissue factor pathway inhibitor in cardiomyocytes and its upregulation by interleukin-1.

+ cite this

+ View Abstract

Kereveur A, Enjyoji K, Masuda K, Yutani C, and Kato H

Thrombosis and haemostasis 86(5):1314-9, 2001 Nov - Who cited this? | PubMed ID: 11816723 | Fulltext

Assignment of ecto-nucleoside triphosphate diphosphohydrolase-1/cd39 expression to microglia and vasculature of the brain.

+ cite this

+ View Abstract

Braun N, Sévigny J, Robson SC, Enjyoji K, Guckelberger O, Hammer K, Di Virgilio F, and Zimmermann H

The European journal of neuroscience 12(12):4357-66, 2000 Dec - Who cited this? | PubMed ID: 11122346 | Fulltext

CD39/vascular ATP diphosphohydrolase modulates xenograft survival.

+ cite this

Imai M, Takigami K, Guckelberger O, Lin Y, Sevigny J, Kaczmarek E, Goepfert C, Enjyoji K, Bach FH, Rosenberg RD, and Robson SC

Transplantation proceedings 32(5):969, 2000 Aug - Who cited this? | PubMed ID: 10936301 | Fulltext

Does hypertension confer a hypercoagulable state in stroke-prone spontaneously hypertensive rats?.

+ cite this

+ View Abstract

Abumiya T, Sakata T, Enjyoji K, Kato H, Kawai J, Suzuki T, Masuda J, Sasaguri T, and Ogata J

Journal of hypertension 18(7):901-9, 2000 Jul - Who cited this? | PubMed ID: 10930188 | Fulltext

Modulation of nucleoside [correction of nucleotide] triphosphate diphosphohydrolase-1 (NTPDase-1)cd39 in xenograft rejection.

+ cite this

+ View Abstract

Imai M, Takigami K, Guckelberger O, Enjyoji K, Smith RN, Lin Y, Csizmadia E, Sévigny J, Rosenberg RD, Bach FH, and Robson SC

Molecular medicine (Cambridge, Mass.) 5(11):743-52, 1999 Nov - Who cited this? | PubMed ID: 10656876 | Fulltext

Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation.

+ cite this

+ View Abstract

Enjyoji K, Sévigny J, Lin Y, Frenette PS, Christie PD, Esch JS, Imai M, Edelberg JM, Rayburn H, Lech M, Beeler DL, Csizmadia E, Wagner DD, Robson SC, and Rosenberg RD

Nature medicine 5(9):1010-7, 1999 Sep - Who cited this? | PubMed ID: 10470077 | Fulltext

Monkey hepatocytes efficiently express tissue factor pathway inhibitor (TFPI), in contrast with human and rat hepatocytes.

+ cite this

+ View Abstract

Hine C, Enjyoji K, Kokame K, Nakamura S, Takei A, Kamikubo Y, Sueishi K, and Kato H

Journal of biochemistry 125(6):1039-47, 1999 Jun - Who cited this? | PubMed ID: 10348905 | Fulltext

A novel degradation pathway of tissue factor pathway inhibitor: incorporation into fibrin clot and degradation by thrombin.

+ cite this

+ View Abstract

Ohkura N, Enjyoji K, Kamikubo Y, and Kato H

Blood 90(5):1883-92, 1997 Sep 1 - Who cited this? | PubMed ID: 9292521 | Fulltext

Effect of depolymerized holothurian glycosaminoglycan (DHG) on tissue factor pathway inhibitor: in vitro and in vivo studies.

+ cite this

+ View Abstract

Nagase H, Enjyoji K, Kamikubo Y, Kitazato KT, Kitazato K, Saito H, and Kato H

Thrombosis and haemostasis 78(2):864-70, 1997 Aug - Who cited this? | PubMed ID: 9268186 | Fulltext

Structure and function of the recombinant fifth domain of human beta 2-glycoprotein I: effects of specific cleavage between Lys77 and Thr78.

+ cite this

+ View Abstract

Hagihara Y, Enjyoji K, Omasa T, Katakura Y, Suga K, Igarashi M, Matsuura E, Kato H, Yoshimura T, and Goto Y

Journal of biochemistry 121(1):128-37, 1997 Jan - Who cited this? | PubMed ID: 9058203 | Fulltext

Effects of recombinant human tissue factor pathway inhibitor on thrombus formation and its in vivo distribution in a rat DIC model.

+ cite this

+ View Abstract

Elsayed YA, Nakagawa K, Kamikubo YI, Enjyoji KI, Kato H, and Sueishi K

American journal of clinical pathology 106(5):574-83, 1996 Nov - Who cited this? | PubMed ID: 8929465 | Fulltext

Measurement of the free form of TFPI antigen in hyperlipidemia. Relationship between free and endothelial cell-associated forms of TFPI.

+ cite this

+ View Abstract

Kokawa T, Enjyoji K, Kumeda K, Kamikubo Y, Harada-Shiba M, Koh H, Tsushima M, Yamamoto A, and Kato H

Arteriosclerosis, thrombosis, and vascular biology 16(6):802-8, 1996 Jun - Who cited this? | PubMed ID: 8640408 | Fulltext

Effect of depolymerized holothurian glycosaminoglycan (DHG) on the activation of factor VIII and factor V by thrombin.

+ cite this

+ View Abstract

Nagase H, Enjyoji K, Shima M, Kitazato K, Yoshioka A, Saito H, and Kato H

Journal of biochemistry 119(1):63-9, 1996 Jan - Who cited this? | PubMed ID: 8907177 | Fulltext

An anti-tissue factor pathway inhibitor (TFPI) monoclonal antibody recognized the third Kunitz domain (K3) of free-form TFPI but not lipoprotein-associated forms in plasma.

+ cite this

+ View Abstract

Abumiya T, Enjyoji K, Kokawa T, Kamikubo Y, and Kato H

Journal of biochemistry 118(1):178-82, 1995 Jul - Who cited this? | PubMed ID: 8537308 | Fulltext

Effect of heparin on the inhibition of factor Xa by tissue factor pathway inhibitor: a segment, Gly212-Phe243, of the third Kunitz domain is a heparin-binding site.

+ cite this

+ View Abstract

Enjyoji K, Miyata T, Kamikubo Y, and Kato H

Biochemistry 34(17):5725-35, 1995 May 2 - Who cited this? | PubMed ID: 7727433 | Fulltext

Depolymerized holothurian glycosaminoglycan with novel anticoagulant actions: antithrombin III- and heparin cofactor II-independent inhibition of factor X activation by factor IXa-factor VIIIa complex and heparin cofactor II-dependent inhibition of thrombin.

+ cite this

+ View Abstract

Nagase H, Enjyoji K, Minamiguchi K, Kitazato KT, Kitazato K, Saito H, and Kato H

Blood 85(6):1527-34, 1995 Mar 15 - Who cited this? | PubMed ID: 7888673 | Fulltext

Amino acid sequence and inhibitory activity of rhesus monkey tissue factor pathway inhibitor (TFPI): comparison with human TFPI.

+ cite this

+ View Abstract

Kamei S, Kamikubo Y, Hamuro T, Fujimoto H, Ishihara M, Yonemura H, Miyamoto S, Funatsu A, Enjyoji K, and Abumiya T

Journal of biochemistry 115(4):708-14, 1994 Apr - Who cited this? | PubMed ID: 8089087 | Fulltext

Response of plasma tissue factor pathway inhibitor to diet-induced hypercholesterolemia in crab-eating monkeys.

+ cite this

+ View Abstract

Abumiya T, Nakamura S, Takenaka A, Takenaka O, Yoshikuni Y, Miyamoto S, Kimura T, Enjyoji K, and Kato H

Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 14(3):483-8, 1994 Mar - Who cited this? | PubMed ID: 8123656 | Fulltext

Human tissue factor pathway inhibitor (TFPI) gene: complete genomic structure and localization on the genetic map of chromosome 2q.

+ cite this

+ View Abstract

Enjyoji K, Emi M, Mukai T, Imada M, Leppert ML, Lalouel JM, and Kato H

Genomics 17(2):423-8, 1993 Aug - Who cited this? | PubMed ID: 8104873 | Fulltext

Purification and characterization of two isoforms of T-kininogens from rat liver microsomes.

+ cite this

+ View Abstract

Enjyoji K and Kato H

Journal of biochemistry 111(5):670-5, 1992 May - Who cited this? | PubMed ID: 1639765 | Fulltext

cDNA cloning and expression of rat tissue factor pathway inhibitor (TFPI).

+ cite this

+ View Abstract

Enjyoji K, Emi M, Mukai T, and Kato H

Journal of biochemistry 111(5):681-7, 1992 May - Who cited this? | PubMed ID: 1639767 | Fulltext

Hydroxylated kininogens and kinins.

+ cite this

+ View Abstract

Kato H and Enjyoji K

Agents and actions. Supplements 38 ( Pt 1):217-24, 1992 - Who cited this? | PubMed ID: 1334619 | Fulltext

Amino acid sequence and location of the disulfide bonds in bovine beta 2 glycoprotein I: the presence of five Sushi domains.

+ cite this

+ View Abstract

Kato H and Enjyoji K

Biochemistry 30(50):11687-94, 1991 Dec 17 - Who cited this? | PubMed ID: 1751487 | Fulltext

Characterization of rat factors X and Xa: demonstration of factor Xa in rat plasma.

+ cite this

+ View Abstract

Enjyoji K, Miyazaki K, and Kato H

Journal of biochemistry 109(6):890-8, 1991 Jun - Who cited this? | PubMed ID: 1718949 | Fulltext

Search Google Scholar for Enjyoji K

Join Labmeeting

Organize and search your PDF collection
Collect papers
Search millions of papers
Keep up to date with paper alerts
Read your papers from anywhere
Recommend papers to colleagues
Manage your lab

Labmeeting is a web service for researchers. Sign up with your academic email address.

Individuals or corporations not affiliated with an academic institution can request a trial subscription.

Got a question?
The Labmeeting Network
has the answer.
Ask scientists at top universities like Harvard, Stanford, and MIT for their expert opinion!